FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

FDA, Big Pharma collaborate on genetic tests

Seven of the world's biggest drug makers are banding together to create a research consortium that will develop genetic tests that can identify patients vulnerable to dangerous adverse events. Under prodding from the FDA, Pfizer, Roche and others will back a research program that will develop tests for serious liver toxicity as well as Stevens-Johnson syndrome. Their work will go into the public domain, available to anyone wishing to develop a genetic test on that data. The development of pharmacogenetics is considered crucial to a new generation of biotech drugs, which are intended to produce higher efficacy rates among smaller groups of patients.

- check out this release for details on the program
- read the article from The New York Times

Related Articles:
House overhauls, passes PDUFA. Report
Bickering may stall trial database. Report
PDUFA debate highlights drug safety issues. Report
Senate toughens drug safety supervision in PDUFA bill. Report

More stories about FDA   Drug Safety   adverse events   Pfizer   Roche   biotech drugs   FDA update   PDUFA   genetic test  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 49 + 31?
To combat spam, please solve the math question above.